Today, I will present the second of the two lectures on neutron interactions.
|
|
- Merilyn Nelson
- 5 years ago
- Views:
Transcription
1 Today, I will present the second of the two lectures on neutron interactions. 1
2 The main goal of this lecture is to tell you a little about clinical neutron therapy, first with fast neutron beams, and then with boron neutron capture. Then we ll discuss contamination neutrons in radiation therapy, both in conventional photon therapy and in proton therapy. Then, we ll talk a little bit about neutron shielding for radiation therapy and some of the things that we consider, especially in the door design. Finally, we ll talk a bit about neutron dose. There are really two big things when we think about neutron dose. There is neutron dose in a high-dose situation, in other words, dose to the patient, and how we calculate that in a clinical facility. And then there is neutron protection, which deals with low-dose quantities. These two subjects are handled are entirely differently from each other. 2
3 The first half of today s lecture will focus on neutron radiotherapy. I will discuss two types of therapy including fast neutron therapy and boron neutron capture therapy. Then I will briefly provide some details about the history of neutron therapy and current facilities and the types of tumors that have been successfully treated with neutrons. 3
4 For most hospital facilities the neutron sources will come from cyclotrons, either from accelerating deuterons or protons and impinging them on a beryllium target. Note that unlike the production of photon beams, in which the accelerated particles impinge on a high-z target, to produce neutron beam the accelerated particles impinge on a low-z target. Now, to have a beam that has a high enough energy to penetrate into tissue of the patient and not cause extreme skin reactions, you need to have those deuterons and protons with energies of at least 50 MeV. And historically neutrons got a really bad rap, because a lot of the early accelerators were low energy, 16 MeV and 26 MeV, and so those beams were not really penetrating very deeply into tissue, and neither the dosimetry nor the radiation biology was very well understood. So the doses they were giving the patients were not very well controlled. In the new facilities, of which there are only actually 3 in the United States, the accelerating potential is greater than 50 MeV. 4
5 When designing a neutron therapy facility, the decision whether to use protons or deuterons to generate a fast neutron beam is greatly affected by the amount of space available for the facility because accelerating deuterons require a cyclotron that is approximately twice the size of a cyclotron to accelerate protons because the mass of a deuteron is twice that of a proton. Such a large cyclotron is impractical for a hospital and would more likely be found at a research facility. 5
6 The first method of generating a fast neutron beam is a stripping process. In this method, deuterons are accelerated to a high energy (>50 MeV) and then impinge on a beryllium-9 target. The deuteron collides with the beryllium target and a proton is stripped from the deuteron and added to the beryllium nucleus, converting it to boron-10. The recoil neutron from the proton-stripped deuteron retains some of the incident kinetic energy of the accelerated deuteron. Some gamma rays are also produced as well. 6
7 This figure shows two neutron spectra resulting from deuteron bombardment of Beryllium. The spectrum on the left is from an older accelerator with deuterons accelerated to 16 MeV, whereas the spectrum on the right is from a newer accelerator in which deuterons are accelerated to 50 MeV. In both spectra there is a single peak, with a modal value of approximately 40% of the energy of the incident deuterons. 7
8 The second method of generating a fast neutron beam is a knock-out process. In this method, protons are accelerated to a high energy, >50 MeV, and then impinged on a beryllium-9 target. The protons knock out neutrons, and for each one of the knocked-out neutrons, you end up with a boron-9 atom. Let us consider an example with a single proton impinging a single beryllium-9 atom. The proton collides with the beryllium-9 target. The proton is added to the beryllium-9 nucleus and a neutron is knocked-out of to the beryllium nucleus, converting it to a boron-9 nucleus. The neutron retains some of the kinetic energy of the incident proton. 8
9 This figure shows two neutron spectra resulting from proton bombardment of beryllium. The dashed line is an unfiltered spectrum that was produced from protons accelerated to 43 MeV. This spectrum spans a wide range of energies from zero up to the energy of the incident protons. The low-energy neutrons in this spectrum are not penetrating enough for therapy and would cause severe skin reaction. These low-energy neutrons must thus be filtered-out. This figure is from the Hall textbook, which says that a low-z material such as polyethylene was used to filter the beam. Polyethylene contains a long chain of hydrocarbons, consequently, there is a large amount of hydrogen to remove the low-energy component. Recall from the previous lecture that elastic scatter dominates for lower energy fast neutrons and that nuclei with lower mass are more effective on a per collision basis for slowing down neutrons. So, a low-z material like polyethylene would reduce the energy of these neutrons to thermal energies. But, just using polyethylene might just make the problem worse because the beam would have even more low-energy neutrons. However, if the polyethylene were doped with a material like boron, which has a high thermal neutron cross section, it would effectively remove the thermalized neutrons from the beam achieving an overall harder spectrum as is shown by the solid line. Consequently, it is very likely that boronated polyethylene was used to filter the beam. 9
10 6 MV is the most commonly used beam energy in photon radiation therapy and thus provides a good frame of reference. The d max for a 6-MV photon beam is 1.5 cm and percent depth dose at 10 cm is approximately 65%. This figure compares isodoses for a fast neutron beam and a 6-MV photon beam. Here, we see that isodose values 70% are very similar for the two beams. However, isodose lines less than 70% are at more shallow depths for neutrons than for photons, resulting in a somewhat steeper fall-off in dose. 10
11 If we compare a neutron beam to a 6-MV photon beam, we observe differences in the machine design. For example, an accelerator that produces photon beams uses high-z materials such as lead or tungsten to collimate the beam. These materials are easily accommodated within the treatment gantry by a target-to-isocenter distance of 100 cm. However, neutron beams require a greater distance between the target and isocenter to accommodate thicker collimators. 11
12 Neutron beams are typically collimated with several different materials designed to remove neutrons. The neutrons are first slowed down with hydrogen-rich materials such as polyethylene. Then an absorbing material is used to remove the thermal neutrons. This is usually followed by a high Z-material to absorb the γ-ray photons that are a byproduct of activation that follows absorption. Because of the large size of the collimator, we use longer treatment distances for neutron therapy, closer to 140 cm. In some facilities, in order to achieve these long distances, the floor of the treatment room actually opens up and the table drops down beneath the floor. 12
13 The first clinical experiences with fast neutron beams were at the Lawrence Berkeley Laboratory in California and at the Hammersmith Hospital in London. We are not going to discuss these experiences in detail, but if you are interested, you can find more details in a radiobiology text such as the Eric Hall textbook, Radiobiology for the Radiologist. 13
14 Currently, there are three neutron therapy facilities in the United States. One facility is the Northern Illinois University Institute for Neutron Therapy at Fermilab. This is an older facility and it s at a research laboratory. Patients at this facility are treated in a sitting position, and there is a beam port that comes out of the wall, which is more like a research beam line. Two newer institutions are at the University of Washington Medical Center and the Gershenson Radiation Oncology Center in Detroit. 14
15 Here is some information about the University of Washington and Gershenson facilities, which are both relatively new. The University of Washington Medical Center uses a cyclotron to accelerate protons. They have a rotating gantry and multileaf collimator in their facility. The Gershenson facility at Wayne State University in Detroit uses a superconducting cyclotron to accelerate deuterons. This is a smaller standard cyclotron, or at least that is what it says on their website. They also have a rotating gantry and are equipped with a multileaf collimator. 15
16 There is evidence that certain subgroups of patients may benefit from neutron therapy compared to high-energy photon therapy. Specifically, neutrons have been shown to be effective for patients with slower growing tumors such as adenoidcystic carcinoma (cancer of parotid glands), locally advanced prostate cancer, locally advanced head and neck tumors, inoperable sarcomas, and cancer of the salivary glands. Slower growing tumors are generally considered to be late responding than early responding tumors. The effectiveness of neutrons for these types of cancer is likely related to the higher LET of neutrons. Remember the dose from neutrons is actually delivered by high-energy charged particles set in motion following interactions between neutrons and nuclei in the tissue. In your radiation biology class you learned (or will learn) that high-let radiation is more likely to result in double strand breaks whereas low-let photons are more likely to result in single strand breaks. Further discussion of this topic is beyond the scope of this course and is covered in the radiation biology course. 16
17 In addition to the information in Chapter 24 of the Eric Hall textbook, Radiobiology for the Radiologist, you may also find the following references of interest. I will not expect you to read these, it is just a list for those who are particularly interested in the topic. 17
18 Let s switch topics and discuss boron neutron capture therapy (BNCT). BNCT uses a neutron beam that interacts with boron injected into a patient. BNCT depends on the interaction of slow neutrons with boron-10 to produce alpha particles and lithium nuclei. The idea behind BNCT is that you preferentially deliver boron to a tumor or a target site that you want to irradiate. Patients are given an intravenous injection of a boron-10 tagged chemical that preferentially binds to tumor cells. The boron has a high cross section for interaction with thermal neutrons, 3837 barns. When the boron absorbs the thermal neutrons you get the reaction between the boron and the neutron. The boron-10 absorbs the thermal energy neutron and ejects a 1.47 MeV short-range alpha particle and 0.84 MeV lithium ion which deposit most of their energy within the cell containing the original boron-10 atom. So if you can infuse the boron into the tumor cell and then put the radiation in, you get the alpha particles out, delivering dose in a region very close to the site of the initial interaction. Thus the dose to your normal tissue is going to be very small; in an ideal situation, you don t have a lot of the boron compound in the normal tissue and the alpha particles are going to deliver the dose quite locally to the tumor. It is a very elegant idea. Some of the complications, however, have been in determining the right boron compound and the preferential absorption of the boron compound between tumor and normal cells. 18
19 In the previous lecture, we saw that there were several nuclei with high thermal absorption cross sections. So, why do we use boron over some of these other nuclei such as cadmium-113, which has a cross section that is five times greater than boron-10? First, boron-10 is non-radioactive and readily available, comprising approximately 20% of naturally occurring boron. Second, the emitted particles (α and 7 Li) have high LET, and their combined path lengths are approximately one cell diameter; i.e., about 12 microns. Theoretically, this limits the deposition of radiation dose to those tumor cells that have taken up a sufficient amount of 10 B, and simultaneously sparing normal cells. Finally, the chemistry of boron is well understood and allows it to be readily incorporated into a multitude of different chemical structures. 19
20 An important consideration for BNCT is that thermal neutrons are not very penetrating and external irradiation with thermal neutrons would really only be effective for very shallow tumors. Therefore in reality, the patient is irradiated with epithermal neutrons, which are thermalized within the superficial tissues via elastic scatter collisions with hydrogen. While this improves the penetration compared to thermal neutrons and reduces the skin dose, the peak doses are still somewhat shallow, typically occurring at 2 to 3 cm. 20
21 This slide is a schematic of the boron-10 interaction s involved in BNCT. As I indicated previously, we use an epithermal neutron beam, rather than a thermal neutron beam. The epithermal beam loses energy by elastically scattering with hydrogen in tissue. 21
22 The neutrons become thermalized and are captured by the boron-10 nuclei. These boron-10 nuclei become boron-11 nuclei in a short-lived excited state. 22
23 The boron-11 nuclei then split into alpha particles, lithium-7 nuclei, and gamma rays. 23
24 Sweet and colleagues first demonstrated in 1952 that certain boron compounds would concentrate in human brain tumor relative to normal brain tissue. Shortly thereafter, clinical trials were initiated at Brookhaven National Laboratory and at MIT. Unfortunately, these trials failed to show any evidence of therapeutic efficacy. It became clear later that there were two major reasons for their lack of success. First the study used thermal neutrons, which were insufficiently penetrating and second the boron compounds that were used in the trials were freely diffusible and did not achieve selective localization in the tumor. Later, more encouraging results were observed in clinical studies done in Japan for the treatment of malignant gliomas and melanoma. At present, there are several groups in the U.S. and abroad working on BNCT for melanoma and gliomas. 24
25 The first part of today s lecture dealt with the direct use of neutrons in radiation therapy. The second half of today s lecture will switch gears from therapy and focus on the production of secondary neutrons, that is, contamination neutrons in radiation therapy. 25
26 We find contamination neutrons produced both in x-ray therapy as well as in proton therapy. Contamination neutrons in x-ray therapy result from (γ,n) reactions with high atomic number materials in the head of the linac. We learned about these interactions in our unit on photon interactions with matter. The neutrons come out of the head of the linac and move around essentially isotropically. They can go anywhere in the patient and not just to the target site. So we are thinking about irradiation of distant organs and the induction of secondary cancers to distant organs. We can nicely control the photons so we do not deliver dose to the liver or kidneys when treating the prostate, for example. Because we can t control the direction of the neutron dose, neutron contamination is a serious area of interest in terms of induction of secondary cancers, especially for younger patients. 26
27 Contamination neutrons in proton therapy result from (p,n) reactions with high-z materials in the nozzle, but can also be the result of (p,n) reactions within the patient. Both (γ,n) and (p,n) reactions are threshold reactions. So why do we observe (p,n) and not observe (γ,n) reactions in the patient? It has to do with the energies of the photon and proton beams and the answer to this question should be clear by the end of today s lecture. 27
28 Let s first look at the (γ,n) reactions that we see in the head of a linear accelerator. 28
29 This plot is an example of a spectrum for an 18 MV photon beam. The maximum energy of the photon spectrum is determined by the energy of the electrons incident on the Bremsstrahlung target. In this example, the maximum energy of the electrons was 18 MeV. So, the photon beam has a range of energies from 0 to 18 MeV, with an average energy of approximately 6 MeV. Now, let s consider this spectrum in the context of (γ,n) reaction cross sections and threshold energies. 29
30 This plot, shows the (γ,n) reaction cross section for Pb-207 in black. Note that the threshold energy is slightly greater than 6 MeV and increases rapidly between 6 and about 18 MeV, and then begins to drop. So, in the context of the Bremsstrahlung spectrum on the previous slide, secondary neutrons can be generated from interactions between high-energy photons in that spectrum and Pb-207 in the head of the linear accelerator. Note that there is no production of neutrons from a 6-MV beam because the photon energy is less than the threshold for neutron production. A lot of times you will see in the medical physics literature that you do not need to consider neutron shielding for accelerators operating at energies below 10 MV. It is not that the threshold for neutron production is 10 MeV, but for a 10 MV beam, there will be almost no photons with energies above the threshold region. The (γ,n) reaction cross sections for other high-z materials in the linac head such as tungsten are similar to that of Pb
31 Now let s compare the spectra for 18 MV and 15 MV photon beams. Notice that the 18 MV beam has more photons above the (γ,n) threshold and most are in the region where the (γ,n) cross section dramatically increases. So, how would we expect this to affect neutron contamination. We would expect to see substantially more contamination neutrons for an 18 MV beam compared to a 15 MV beam. And there is, in fact, a twofold increase observed in neutron dose for 18 MV beams compared to 15 MV beams. 31
32 Now, let s consider the reaction cross sections for nuclei in the human body. This is a plot of (γ,n) reaction cross sections for carbon, oxygen, and nitrogen. Nitrogen has the lowest threshold energy at about 8 MeV and carbon has the highest at about 19 MeV. These thresholds are much higher than those observed for high-z materials and there are very few photons in our 15 MV and 18 MV spectra above these thresholds. Also, the magnitude of the reaction cross-sections are an order of magnitude lower than those for high-z materials. Therefore, we can conclude that secondary neutron production is tissue is extremely unlikely and essentially negligible. 32
33 Now, let s look at the neutron spectra emanating from the head of the linear accelerator. We are making the photons from an electron beam. Those photons then hit the collimators, the primary jaws, the flattening filter and the target. And it s from (γ,n) interactions in the linac head that we are getting these secondary neutrons in the therapy beam. The initial distribution of secondary neutrons generated in the linac head from these (γ,n) reactions is approximately isotropic, and the energy distribution actually looks like a fission spectrum. 33
34 The neutron energy then decreases as a consequence of the neutron transport through the components of the treatment head (primary collimators, flattening filter, secondary jaws, MLC, etc). The primary mechanisms of energy loss in high-z materials in the linac head are inelastic scattering and (n,2n) reactions. 34
35 This figure from NCRP-79 compares a 252 Cf fission spectrum to a photoneutron spectrum for 15 MeV electrons striking a tungsten target (designated 15 MeV W PN bare). You can see that these two spectra are very similar. Also shown is the photoneutron spectrum with 10 cm of tungsten to simulate materials in the gantry head. Notice that the energy is decreased as a consequence of inelastic scatter and (n,2n) reactions. Also shown is a spectrum with 10 cm of tungsten shielding inside a concrete room to simulate materials in the gantry head in an actual treatment vault. The energy is further reduced from elastic scatter with low-z materials in the concrete. 35
36 This figure shows photoneutron spectra measured for a Varian linac operated at 3 different beam energies 15, 18, and 20 MV. Notice that qualitatively these spectra are similar, with fast neutron peaks centered at approximately 0.23 MeV and have similar average energies. Each spectrum also has a low-energy tail that arose from neutrons scattered throughout the treatment vault. The obvious distinction between the three spectra is the total neutron fluence per MU. A 1.7-fold increase in fluence was observed as the energy increased from 15 to 18 MV and a 1.4-fold increase was observed as energy was increased from 18 to 20 MV. 36
37 The other set of reactions that produce secondary neutrons that we might find of interest are the (p,n) reactions, which cause secondary neutron production in proton beams. 37
38 There are several significant differences between proton beams and x-ray beams that need to be taken into consideration when looking at the production of contamination neutrons. First of all, we need to look at the energy spectra of typical clinical proton beams. Clinical proton beams have a much smaller energy spread compared to photon beams, and the maximum energies of proton beams are considerably higher, typically in the range of MeV. 38
39 This plot shows the (p,n) reaction cross section for Pb-207 in black. Note that the threshold energy is approximately 10 MeV and increases rapidly with energy. So, in the context of the energies used for clinical proton beam therapy, neutrons can be generated from interactions between high-energy protons in that spectrum and Pb-207 in the nozzle. Also, the magnitude of the (p,n) cross sections are an order of magnitude greater than the magnitude of the (γ,n) cross sections. The (p,n) reaction cross sections for other high-z materials in the linac head such as tungsten are similar to that of Pb-207. So the amount of contamination neutrons in a proton beam is going to be much greater than the neutron contamination in a photon beam. 39
40 Now, let s consider the reaction cross sections for nuclei in the human body. This is a plot of (p,n) reaction cross sections for carbon-12. The threshold is somewhat higher than that for Pb-207, but still well below the energy of a clinical proton beam. Therefore, we can conclude that in contrast to our observation that (γ,n) reactions in tissue are extremely unlikely for a clinical photon beam, (p,n) reactions in tissue can occur in a clinical proton beam, and this neutron contamination dose is not negligible. 40
41 These data are a plot of Monte Carlo simulated neutron spectra for clinical proton beams. These neutron spectra were generated via (p,n) reactions. Note that there are two pronounced peaks in all neutron spectra, joining each other at approximately 10 MeV. The low-energy peak is similar in shape for all proton energies, with neutron energies ranging from 0 to about 10 MeV, and having a modal energy of about 1 MeV. These low-energy neutrons are mainly produced from evaporation processes and are isotropically distributed. The high-energy neutron peak starts at about 10 MeV and extends up to the maximum proton energy, with the modal energy varying with the proton energy. The high-energy peak contains forward-peaked neutrons from direct (nucleon nucleon) reactions produced in intranuclear cascades and neutrons ejected from the compound-nucleus and pre-equilibrium processes. The major difference between secondary neutrons from proton and photon beams is the energy; neutrons from proton beams have much higher energy. This results from the much higher maximum energy of proton beams (~range: 100 MeV to 250 MeV) versus the maximum energy of photons (~ range: 10 MV to 25 MV) energy of the incident photon. 41
42 Finally, this slide gives you a set of references on neutrons. 42
43 43
Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics
Neutron Interactions Part 2 George Starkschall, Ph.D. Department of Radiation Physics Neutron shielding Fast neutrons Slow down rapidly by scatter in hydrogenous materials, e.g., polyethylene, paraffin,
More informationNeutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction
Neutrons Neutrons act like photons in the sense that they are attenuated as I = I 0 e μx where Unlike photons, neutrons interact via the strong interaction μ = The cross sections are much smaller than
More informationAN ABSTRACT OF THE THESIS OF. Leanna R. Eller for the degree of Master of Science in Radiation Health Physics
AN ABSTRACT OF THE THESIS OF Leanna R. Eller for the degree of Master of Science in Radiation Health Physics presented on November 30, 2010. Title: An Investigation on Photoneutron Production from Medical
More informationNeutron dose evaluation in radiotherapy
Neutron dose evaluation in radiotherapy Francesco d Errico University of Pisa, Italy Yale University, USA Radiation therapy with a linear accelerator (LINAC) Photoneutron production in accelerator head
More informationUse of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments
Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments Alana Hudson *1 1 Tom Baker Cancer Centre, Department of Medical Physics, 1331
More informationChapter Introduction
Chapter 1 Introduction Malignancy is a life-threatening condition in which tumor cells are of a highly invasive character and penetrate normal organs and exhibit an obstinate resistance against cancer
More informationA Feasibility Study of the SLOWPOKE-2 Reactor as a Neutron Source for Boron Neutron Cancer Treatment
A Feasibility Study of the SLOWPOKE- Reactor as a Neutron Source for Boron Neutron Cancer Treatment Introduction M.J. McCall, M. Pierre Royal Military College of Canada, Kingston, Ontario, Canada K7K 7B4
More informationNeutron Measurements for Intensity Modulated Radiation Therapy
SLAC-PUB-8443 April 2 Neutron Measurements for Intensity Modulated Radiation Therapy N. E. Ipe et al. Presented at Chicago 2 World Congress on Medical Physics and Biomedical Engineering, 7/23/2 7/28/2,
More informationEpithermal neutron beams from the 7 Li(p,n) reaction near the threshold for neutron capture therapy
IL NUOVO CIMENTO 38 C (2015) 179 DOI 10.1393/ncc/i2015-15179-9 Colloquia: UCANS-V Epithermal neutron beams from the 7 Li(p,n) reaction near the threshold for neutron capture therapy I. Porras( 1 ),J.Praena(
More informationTHERMOLUMINESCENT (TL) DOSIMETRY OF SLOW-NEUTRON FIELDS AT RADIOTHERAPY DOSE LEVEL
THERMOLUMINESCENT (TL) DOSIMETRY OF SLOW-NEUTRON FIELDS AT RADIOTHERAPY DOSE LEVEL G. Gambarini Dipartimento di Fisica dell Università, Milano, Italy e-mail grazia.gambarini http://users.unimi.it/~frixy/
More informationProton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania
Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.
More informationTHE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin
THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY S.V. Akulinichev, A. V. Andreev, V.M. Skorkin Institute for Nuclear Research of the RAS, Russia THE PROJECT OF NEUTRON SOURCES FOR THE NEUTRON
More informationIII. Proton-therapytherapy. Rome SB - 5/5 1
Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier
More informationV. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT
CYRIC Annual Report 2002 V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT Yonai S., ItogaT., Nakamura T., Baba M., Yashima, H. Yokobori H. *, and Tahara Y. ** Cyclotron
More informationSHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES
SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES MELISSA C. MARTIN, M.S., FACR, FAAPM PRESIDENT AAPM - 2017 PRESIDENT - THERAPY PHYSICS INC., GARDENA, CA MELISSA@THERAPYPHYSICS.COM AAPM Spring
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationThe physics of boron neutron capture therapy: an emerging and innovative treatment for glioblastoma and melanoma
Physics and Astronomy Department Physics and Astronomy Comps Papers Carleton College Year 2005 The physics of boron neutron capture therapy: an emerging and innovative treatment for glioblastoma and melanoma
More informationBIOLOGICAL EFFECTS OF
BIOLOGICAL EFFECTS OF RADIATION Natural Sources of Radiation Natural background radiation comes from three sources: Cosmic Radiation Terrestrial Radiation Internal Radiation 2 Natural Sources of Radiation
More informationProduction and dosimetry of simultaneous therapeutic photons and electrons beam by linear accelerator: a monte carlo study
Production and dosimetry of simultaneous therapeutic photons and electrons beam by linear accelerator: a monte carlo study Navid Khledi 1, Azim Arbabi 2, Dariush Sardari 1, Mohammad Mohammadi 3, Ahmad
More informationHEAVY PARTICLE THERAPY
HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER
More informationNon-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.
Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact Stephen F. Kry, Ph.D., D.ABR. Goals Compare out-of-field doses from various techniques Methods to reduce out-of-field doses Impact of
More informationNeutron - a tool in the cancer treatment - C. Paunoiu
Neutron - a tool in the cancer treatment - C. Paunoiu 146 5/17/2009 The neutron -a a tool in the cancer treatment Dr.Constantin PĂUNOIU, constantin.paunoiu@nuclear.ro http://www.nuclear.ro biological material
More informationIntroduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.
Measurement of Secondary Radiation for Electron and Proton Accelerators D. Followill, Ph.D. Radiological Physics Center U. T. M. D. Anderson Cancer Center Introduction Patients undergoing radiation therapy
More informationNeutron Radiotherapy: Past, Present, and Future Directions
Neutron Radiotherapy: Past, Present, and Future Directions Theodore L. Phillips Lecture -- 2014 George E. Laramore Ph.D., M.D. NONE Conflicts of Interest Peter Wootton Professor of Radiation Oncology University
More informationGDR in Radiotherapy Treatment Fields with 18 MV Accelerators
GDR in Radiotherapy Treatment Fields with 18 MV Accelerators R. R. Martín-Landrove 1, J. Dávila 1, H. R. Vega-Carrillo 2, M. T. Barrera 3, A.J. Kreiner 4, F. Pino 3, H. Barros 3, E. D. Greaves 3 and L.
More informationDjoko S. Pudjorahardjo, Widarto, Isman Mulyadi T
Indonesian Journal of Physics and NuclearApplications Volume 3, Number 1, February 2018, p. 15-20 e-issn 2550-0570, FSM UKSWPublication 2549-046X, FSM UKSWPublication Detail Engineering Design of Compact
More informationPROGRESS IN HADRONTHERAPY
PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy
More informationDistribution of Water Phantom BNCT Kartini Research Reactor Based Using PHITS
Indonesian Journal of Physics and Nuclear Applications Volume 3, Number 2, June 2018, p. 43-48 e-issn 2550-0570, FSM UKSW Publication Distribution of Water Phantom BNCT Kartini Research Reactor Based Using
More informationA Monte Carlo Study for Photoneutron Dose Estimations around the High-Energy Linacs
www.jbpe.org A Monte Carlo Study for Photoneutron Dose Estimations around the High-Energy Linacs Original 1 Physics Department, Faculty of Sciences, Ferdowsi University of Mashhad, Iran Mohammadi N 1,
More informationHEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante
HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS Prof. Marco Durante Risk from neutrons Risk from exposure to fission spectrum neutrons has been extensively studied in the 60 s at nuclear reactors using animal
More informationPreliminary study of MAGAT polymer gel dosimetry for boron-neutron capture therapy
Journal of Physics: Conference Series OPEN ACCESS Preliminary study of MAGAT polymer gel dosimetry for boron-neutron capture therapy To cite this article: Shin-ichiro Hayashi et al 2015 J. Phys.: Conf.
More informationShielding Design Basis and its Calculation of High Energy Medical Linac Installed in Bangladesh Atomic Energy Commission, Bangladesh
Universal Journal of Medical Science 5(2): 27-31, 2017 DOI: 10.13189/ujmsj.2017.050202 http://www.hrpub.org Shielding Design Basis and its Calculation of High Energy Medical Linac Installed in Bangladesh
More informationThe title of the presentation is: Neutron production with clinical LINACs for BNCT studies in physical, medical and biological fields.
The title of the presentation is: Neutron production with clinical LINACs for BNCT studies in physical, medical and biological fields. 1 Neutron production with clinical e-linac s is acheived by in-hospital
More informationMedical Use of Radioisotopes
Medical Use of Radioisotopes Therapy Radioisotopes prove to be useful in the application of brachytherapy, the procedure for using temporary irradiation close to the area of disease (i.e. cancer) 10% Medical
More informationSUMITOMO Particle Therapy Technologies
55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future
More informationNeutron Detection Spring 2002
Neutron Detection 22.104 Spring 2002 Neutrons vs. X-rays Ideal Large Detector Pulse Height Neutron Interactions Total Cross section for Moderators Neutron Slowing Down Neutron Histories in Moderated Detector
More informationRadiation qualities in carbon-ion radiotherapy at NIRS/HIMAC
Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:
More informationNEUTRON THERAPY PLANNING
NEUTRON THERAPY PLANNING University of Washington Seattle, WA Patricia Sponseller, MS, CMD, RTT (R)(T) 1 2 3 4 Alex Levine Photography 5 6 THANK YOU! Rob Emery, MS Ruedi Risler, PhD Donna Kubik, MS Tom
More informationCharacterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca
More informationAAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy
AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy Stephen F. Kry a) Department of Radiation Physics, MD Anderson Cancer Center, Houston,
More informationRadiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada
Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Overview Introduction Overview Introduction Brachytherapy Radioisotopes in contact with the tumor Overview
More informationADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER
ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER Bro. Dr. Collie Miller IARC/WHO Based on trends in the incidence of cancer, the International Agency for Research on Cancer (IARC) and WHO
More informationCamille J. Lodwick. Photoneutron contamination produced during high-energy, external beam
AN ABSTRACT OF THE THESIS OF Mary Elizabeth Catchpole for the degree of Master of Science in Medical Physics presented on December 1, 2010. Title: Comparison of Secondary Neutron Dose from 10 MV Intensity
More informationOption D: Medicinal Chemistry
Option D: Medicinal Chemistry Basics - unstable radioactive nuclei emit radiation in the form of smaller particles alpha, beta, positron, proton, neutron, & gamma are all used in nuclear medicine unstable
More informationUse of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation.
Radiation Therapy Use of radiation to kill diseased cells. Cancer is the disease that is almost always treated when using radiation. One person in three will develop some form of cancer in their lifetime.
More informationOptimization of an accelerator-based epithermal neutron source for neutron capture therapy
Applied Radiation and Isotopes 61 (2004) 1009 1013 Optimization of an accelerator-based epithermal neutron source for neutron capture therapy O.E. Kononov a, *, V.N. Kononov a, M.V. Bokhovko a, V.V. Korobeynikov
More informationStudy on Microdosimetry for Boron Neutron Capture Therapy
Progress in NUCLEAR SCIENCE and TECHNOLOGY, Vol. 2, pp.242-246 (2011) ARTICLE Study on Microdosimetry for Boron Neutron Capture Therapy Tetsuya MUKAWA 1,*, Tetsuo MATSUMOTO 1 and Koji NIITA 2 1 Tokyo City
More informationSarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington
Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation
More informationCOMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE
COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone
More informationNature of Radiation and DNA damage
Nature of Radiation and DNA damage Index 1. What is radiation? 2. Ionizing Radiation 3. Interaction of Gamma-radiation with Matter 4. Radiobiology 5. Direct and Indirect action of radiation 6. Steps of
More informationCOMPARING THE RESPONSES OF TLD 100, TLD 600, TLD 700 AND TLD 400 IN MIXED NEUTRON-GAMMA FIELDS
2015 International Nuclear Atlantic Conference - INAC 2015 São Paulo, SP, Brazil, October 4-9, 2015 ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR - ABEN ISBN: 978-85-99141-06-9 COMPARING THE RESPONSES OF TLD
More informationRadiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.
Radiation Related Second Cancers Stephen F. Kry, Ph.D., D.ABR. Objectives Radiation is a well known carcinogen Atomic bomb survivors Accidental exposure Occupational exposure Medically exposed Radiotherapy
More informationRadiation protection in proton therapy
Radiation protection in proton therapy Pieternel van der Tol Medical Physicist - HollandPTC pvandertol@hollandptc.nl Marjan Dwarswaard René Bolt Marc-Jan van Goethem Lars Murrer Outline Introduction Interactions
More informationPeak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam
Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam University of Chicago CDH Proton Center LET study C. Reft 1, H. Ramirez 2 and M. Pankuch
More informationSources of ionizing radiation Atomic structure and radioactivity Radiation interaction with matter Radiation units and dose Biological effects
INTRODUCTION TO RADIATION PROTECTION Sources of ionizing radiation Atomic structure and radioactivity Radiation interaction with matter Radiation units and dose Biological effects 3/14/2018 1 Wilhelm C.
More informationPHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5)
PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5) 1. (a) A radioisotope is an isotope that is unstable and will emit particles from the nucleus
More informationDesign of a BSA for Producing Epithermal Neutron for BNCT
Siam Physics Congress 2015 Design of a BSA for Producing Epithermal Neutron for BNCT M Asnal *, T Liamsuwan 2 and T Onjun 1 1 Sirindhorn International Institute of Technology, Thammasat University 2 Nuclear
More informationLecture 13 Radiation Onclolgy
Lecture 13 Radiation Onclolgy Radiation Oncology: Tumors attacked with ionizing radiation Photons (gamma rays) High Energy Electrons Protons Other particles Brachytherapy: implants of beta emitters Ionizing
More informationElectron therapy Class 3: Clinical procedures
Electron therapy Class 3: Clinical procedures Laurence Court lecourt@mdanderson.org Reference: Faiz M. Khan, The Physics of Radiation Therapy Slide acknowledgements: Karl Prado, Rebecca Howell, Kent Gifford,
More informationProgress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute
Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute Yoshinori Sakurai 1 Kyoto University Research Reactor Institute Asashiro-nishi 2-1010, Kumatori-cho, Sennan-gun,
More informationIntensity Modulated RadioTherapy
Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June
More informationPHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)
PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce
More informationTFY4315 STRÅLINGSBIOFYSIKK
Norges teknisk-naturvitenskaplige universitet Institutt for fysikk EKSAMENSOPPGÅVER med løysingsforslag Examination papers with solution proposals TFY4315 STRÅLINGSBIOFYSIKK Biophysics of Ionizing Radiation
More information6) Radiation Protection (1) Radiation effects in biological material (cells)
6) Radiation Protection (1) Three phase model of biological effects on organisms: Outer irradiation Physical Phase Chemical Phase Internal irradiation Radiolysis, peroxide formation Ionisation and excitation
More informationReal Time Spectrometer for thermal neutrons from Radiotherapic Accelerators
Real Time Spectrometer for thermal neutrons from Radiotherapic Accelerators Aldo Mozzanica, Università degli Studi di Brescia, INFN sezione di Pavia mozzanica@bs.infn.it 2 Outlines The Boron Neutron Capture
More informationBoron Neutron Capture Therapy (BNCT) - Low-Energy Neutron Spectrometer for Neutron Field Characterization - )
Boron Neutron Capture Therapy (BNCT) - Low-Energy Neutron Spectrometer for Neutron Field Characterization - ) Isao MURATA and Tsubasa OBATA Division of Electrical, Electronic and Information Engineering,
More informationNPTEL NPTEL ONLINE COURSE. NPTEL Online Certification Course (NOC) NPTEL. Theory and Practice of Non Destructive Testing
NPTEL NPTEL ONLINE COURSE NPTEL Online Certification Course (NOC) NPTEL Theory and Practice of Non Destructive Testing Dr. Ranjit Bauri Dept. of Metallurgical & Materials Engineering IIT Madras, Chennai
More informationFirst, how does radiation work?
Hello, I am Prajnan Das, Faculty Member in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center. We are going to talk today about some of the basic principles regarding
More informationEQUIVALENT DOSE FROM SECONDARY NEUTRONS AND SCATTER PHOTONS IN ADVANCE RADIATION THERAPY TECHNIQUES WITH 15 MV PHOTON BEAMS
PAPER EQUIVALENT DOSE FROM SECONDARY NEUTRONS AND SCATTER PHOTONS IN ADVANCE RADIATION THERAPY TECHNIQUES WITH 15 MV PHOTON BEAMS Isra Israngkul Na Ayuthaya *, Sivalee Suriyapee, Phongpheath Pengvanich
More informationApplications of Particle Accelerators
Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy
More informationDevelopment of a Thermal Neutron Source based on a Medical Electron Linac
Development of a Thermal Neutron Source based on a Medical Electron Linac Valeria Monti December 15 th, 2016 Second Year Seminar, XXX cycle Outline E_LiBANS project Physics of the thermal photo-neutron
More informationDevelopment of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba )
Development of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba ) Hiroaki KUMADA, Fujio NAITO 1), Kazuo HASEGAWA 2), Hitoshi KOBAYASHI 1), Toshikazu KURIHARA 1), Kenta
More informationNuclear Data for Radiation Therapy
Symposium on Nuclear Data 2004 Nov. 12, 2004 @ JAERI, Tokai Nuclear Data for Radiation Therapy ~from macroscopic to microscopic~ Naruhiro Matsufuji, Yuki Kase and Tatsuaki Kanai National Institute of Radiological
More informationStudy of neutron-dna interaction at the IPEN BNCT Research facility ABSTRACT
Study of neutron-dna interaction at the IPEN BNCT Research facility Maritza Rodriguez Gual 1, Oscar Rodriguez Hoyos 1, Fernando Guzman Martinez 1, Airton Deppman 2, J.D.T.Aruda Neto 2, V.P.Likhachev 2,
More informationIonizing Radiation. Alpha Particles CHAPTER 1
CHAPTER 1 Ionizing Radiation Ionizing radiation is radiation that has sufficient energy to remove electrons from atoms. In this document, it will be referred to simply as radiation. One source of radiation
More informationSpatially Fractionated Radiation Therapy: GRID Sponsored by.decimal Friday, August 22, Pamela Myers, Ph.D.
Spatially Fractionated Radiation Therapy: GRID Sponsored by.decimal Friday, August 22, 2014 Pamela Myers, Ph.D. Introduction o o o o o Outline GRID compensator Purpose of SFRT/GRID therapy Fractionation
More informationExpectations of Physics Knowledge for Certification
Expectations of Physics Knowledge for Certification Bhudatt Paliwal, Ph.D. University of Wisconsin Medical School Department of Human Oncology Madison, Wisconsin 53792 USA Guiding Principles Test that
More informationBinary therapies in the treatment of cancer
Binary therapies in the treatment of cancer translational research from the physics laboratory to the clinic Stuart Green University Hospital Birmingham and British Institute of Radiology STFC Innovations
More informationRadiation Protection in BNCT Patients
Radiation Protection in BNCT Patients J. Kessler 2, H. Blaumann 1, D. Feld 2,, E. Scharnichia 1, I. Levanón 1, C. Fernández 1, G. Facchini 1, M. Casal 3, S. González 2, J. Longhino 1, O. Calzetta 1, B.
More informationSingle Photon Emission Tomography Approach for Online Patient Dose Assessment in Boron Neutron Capture Therapy
Single Photon Emission Tomography Approach for Online Patient Dose Assessment in Boron Neutron Capture Therapy Daniel M Minsky a,b,c*, Alejandro Valda a,b, Andrés J Kreiner a,b,c and Alejandro A Burlon
More informationIMRT Planning Basics AAMD Student Webinar
IMRT Planning Basics AAMD Student Webinar March 12, 2014 Karen Chin Snyder, MS Senior Associate Physicist Department of Radiation Oncology Disclosures The presenter has received speaker honoraria from
More informationThe ANDANTE project: a multidisciplinary approach to neutron RBE
The ANDANTE project: a multidisciplinary approach to neutron RBE Andrea Ottolenghi, Klaus Trott, Giorgio Baiocco, Vere Smyth Università degli Studi di Pavia, Italy On behalf of the ANDANTE project MELODI
More informationDesign and Performance Of A Thermal Neutron Beam for Boron Neutron Capture Therapy At The University Of Missouri Research Reactor
Design and Performance Of A Thermal Neutron Beam for Boron Neutron Capture Therapy At The University Of Missouri Research Reactor J.D. Brockman J.C. McKibben In situ activation reaction, 10 B(n, a) 7 Li;
More informationRadioactivity. Alpha particles (α) :
Radioactivity It is the property of an element that causes it to emit radiation Discovered by Becquerel (1896) Radiation comes from the nucleus of the atom There are three types of radiation : alpha particles
More informationMonte Carlo Modelling: a reliable and efficient tool in radiation dosimetry
Monte Carlo Modelling: a reliable and efficient tool in radiation dosimetry G. Gualdrini, P. Ferrari ENEA Radiation Protection Institute, Bologna (Italy) Contribution to the Italy in Japan 2011 initiative
More informationOutline. Outline 3/30/12. Second Cancers from. Radiotherapy Procedures. Stephen F. Kry, Ph.D., D.ABR.
Second Cancers from Radiotherapy Procedures Stephen F. Kry, Ph.D., D.ABR. Outline Radiation and cancer induction Medically exposed people Estimating risk of second cancers Minimizing the risk Outline Radiation
More informationFigure 1.1 PHITS geometry for PTB irradiations with: broad beam, upper panel; mono energetic beams, lower panel. Pictures of the setups and of the
Figure 1.1 PHITS geometry for PTB irradiations with: broad beam, upper panel; mono energetic beams, lower panel. Pictures of the setups and of the PMMA ring holder with 7 containers are also shown. Relative
More informationBiological Effects of Ionizing Radiation & Commonly Used Radiation Units
INAYA MEDICAL COLLEGE (IMC) RAD 232 - LECTURE 2 & 3 Biological Effects of Ionizing Radiation & Commonly Used Radiation Units DR. MOHAMMED MOSTAFA EMAM How does radiation injure people? - High energy radiation
More informationInvestigating a cyclotron HM-30 based neutron source for BNCT of deep-seated tumors by using shifting method
Journal of Physics: Conference Series PAPER OPEN ACCESS Investigating a cyclotron HM-30 based neutron source for BNCT of deep-seated tumors by using shifting method To cite this article: Suharyana et al
More informationI. Equipments for external beam radiotherapy
I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationRadiation Dosimetry at the BNL High Flux Beam Reactor and Medical Research Reactor
BNL-66807 1 1 1 1 2 Holden, N.E., Hu, J-P., Greenberg, D.D., Reciniello, R.N., Farrell, K. and Greenwood, L.R. Radiation Dosimetry at the BNL High Flux Beam Reactor and Medical Research Reactor Reference:Holden,N.E.,
More informationNeutron Induced Radiation Damage in BaF 2, LYSO and PWO Scintillation Crystals
Neutron Induced Radiation Damage in BaF 2, LYSO and PWO Scintillation Crystals Chen Hu, Fan Yang, Liyuan Zhang, Ren-Yuan Zhu California Institute of Technology Jon Kapustinsky, Ron Nelson and Zhehui Wang
More informationHigh brightness electron beam for radiation therapy A new approach
High brightness electron beam for radiation therapy A new approach Wei Gai ( 盖炜 ) Engineering Physics Department, Tsinghua University, Beijing, China Argonne National Laboratory, Argonne, IL 60439, USA
More informationChapters from Clinical Oncology
Chapters from Clinical Oncology Lecture notes University of Szeged Faculty of Medicine Department of Oncotherapy 2012. 1 RADIOTHERAPY Technical aspects Dr. Elemér Szil Introduction There are three possibilities
More informationThin Beryllium target for 9 Be(d,n)- driven BNCT
Thin Beryllium target for 9 Be(d,n)- driven BNCT M.E.Capoulat 1-3, D.M.Minsky 1-3, L.Gagetti 1-3, M. Suárez Anzorena 1, M.F.del Grosso 1-2, J.Bergueiro 1, D.Cartelli 1-3, M.Baldo 1, W.Castell 1, J.Gomez
More informationRadiation Protection: Are We Doing Enough To Protect Our Patients and Staff?
Radiation Protection: Are We Doing Enough To Protect Our Patients and Staff? Wayne Newhauser, Ph. D. Univiversity Texas M. D. Anderson Cancer Center Proton Therapy Course, 2008-05-21, Jacksonville Acknowledgments
More informationSkyscan 1076 in vivo scanning: X-ray dosimetry
Skyscan 1076 in vivo scanning: X-ray dosimetry DOSIMETRY OF HIGH RESOLUTION IN VIVO RODENT MICRO-CT IMAGING WITH THE SKYSCAN 1076 An important distinction is drawn between local tissue absorbed dose in
More informationBiological Effects of Ionizing Radiation & Commonly Used Radiation Units
INAYA MEDICAL COLLEGE (IMC) RAD 232 - LECTURE 3, 4 & 5 Biological Effects of Ionizing Radiation & Commonly Used Radiation Units DR. MOHAMMED MOSTAFA EMAM How does radiation injure people? - High energy
More informationPresented by Dr. Amir H. Mohagheghi. Annual RMCC Workshop Middle East Scientific Institute for Security (MESIS) Amman, Jordan June 17-19, 2013
Neutron Activation Analysis and Dosimetry based on reports by R. Burrows, A. Mohagheghi, and D. Ward: Personnel Nuclear Accident Dosimetry at Sandia National Laboratories SAND96-2204, SAND2011-6416 Presented
More information